William Pao
Direttore/Membro del Consiglio presso Transcelerate Biopharma, Inc.
Patrimonio netto: 2 M $ in data 30/04/2024
Posizioni attive di William Pao
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Direttore/Membro del Consiglio | - | - |
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di William Pao
Precedenti posizioni note di William Pao
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PFIZER, INC. | Corporate Officer/Principal | 21/03/2022 | 15/08/2023 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/05/2014 | 18/03/2022 |
| My Cancer Genome | Fondatore | - | - |
The Vanderbilt-Ingram Cancer Center
 The Vanderbilt-Ingram Cancer Center Hospital/Nursing ManagementHealth Services The Vanderbilt-Ingram Cancer Center engages in the prevention, diagnosis, and treatment of cancer. The non-profit company is based in Nashville, TN. | Corporate Officer/Principal | - | - |
| Vanderbilt University | Corporate Officer/Principal | - | - |
Formazione di William Pao
| Harvard University | Undergraduate Degree |
| Yale University | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 9 |
| Svizzera | 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ROCHE HOLDING AG | Health Technology |
| Aziende private | 4 |
|---|---|
American Association for Cancer Research
American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Commercial Services |
The Vanderbilt-Ingram Cancer Center
The Vanderbilt-Ingram Cancer Center Hospital/Nursing ManagementHealth Services The Vanderbilt-Ingram Cancer Center engages in the prevention, diagnosis, and treatment of cancer. The non-profit company is based in Nashville, TN. | Health Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
| My Cancer Genome |
- Borsa valori
- Insiders
- William Pao
- Esperienza